Monthly Archives: July 2016

Black men with low-risk prostate cancer (PCa) are slightly more likely than their white counterparts to switch to active treatment after initial observational management, independent of baseline and follow-up clinical measures, according to a new study. The study also confirmed previously identified clinical triggers of initiating active treatment, and these factors did not vary by […]

The role of immunotherapy may have had a slower uptick in patients with prostate cancer compared with other tumor types, but progress is being made, explains Akash Patnaik, MD, PhD, an assistant professor of Medicine at the University of Chicago Medicine. Aside from the immuno-based agent sipuleucel-T (Provenge), Patnaik discussed the status with immunotherapy and […]

For the first time, a study has provided evidence of meaningful clinical activity for programmed death 1 (PD-1) blockade in men with metastatic castration-resistant prostate cancer (mCRPC), according to a new report. In an ongoing phase II study, a team led by Julie N. Graff, MD, of the Oregon Health & Science University (OHSU) Knight […]

Researchers have uncovered racial disparities in nutrition among bladder cancer survivors that possibly help explain the racial differences in longevity. The study was presented at the American Urological Association 2016 annual meeting. Although African Americans have a lower risk of developing bladder cancer than Caucasians, they have a higher mortality risk from the disease. Lifestyle […]

A patient’s right to participate in medical decision making through the informed consent process does not cease because the patient lacks decision-making capacity.  If the health care provider determines that the patient lacks capacity, the patient’s right can transfer to the patient’s designated agent, acting under a health care power of attorney. An agent’s authority […]

COMPANY NAME
Dolor aliquet augue augue sit magnis, magna aenean aenean et! Et tempor, facilisis cursus turpis tempor odio. Diam lorem auctor sit, a a? Lundium placerat mus massa nunc habitasse.
  • Goblinus globalus fantumo tubus dia montes
  • Scelerisque cursus dignissim lopatico vutario
  • Montes vutario lacus quis preambul denlac
  • Leftomato denitro oculus softam lorum quis
  • Spiratio dodenus christmas gulleria tix digit
  • Dualo fitemus lacus quis preambul patturtul
CONTACT US
Thank You. We will contact you as soon as possible.
COMPANY NAME
CONTACT US
Dolor aliquet augue augue sit magnis, magna aenean aenean et! Et tempor, facilisis cursus turpis tempor odio putonius mudako empero brutto populius giten facilisis cursus turpis balocus tredium todo.
Thank You. We will contact you as soon as possible.
Do you want massive traffic?
Scelerisque augue ac hac, aliquet, nascetur turpis. Augue diam phasellus odio lorem integer, aliquam aliquam sociis nisi adipiscing hacac.
  • Goblinus globalus fantumo tubus dia
  • Scelerisque cursus dignissim lopatico
  • Montes vutario lacus quis preambul
  • Leftomato denitro oculus softam lorum
  • Spiratio dodenus christmas gulleria tix
  • Dualo fitemus lacus quis preambul bela
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
* we never share your details with third parties.
mCRPC Master
*MANAGE METASTATIC CASTRATION-RESISTANT CANCER TREATMENT FROM YOUR MOBILE DEVICE

* Downloaded from the Apple Store
* FREE for one year.
* Simple, intuitive interface
* Doctors enter the patient's lab values.
* Review symptoms and treatment history
* Generates a comprehensive treatment plan.
AppleStore
AppleStore
Do you want massive traffic?
Scelerisque augue ac hac, aliquet, nascetur turpis. Augue diam phasellus odio lorem integer, aliquam aliquam sociis nisi adipiscing hacac.
  • Goblinus globalus fantumo tubus dia
  • Scelerisque cursus dignissim lopatico
  • Montes vutario lacus quis preambul
  • Leftomato denitro oculus softam lorum
  • Spiratio dodenus christmas gulleria tix
  • Dualo fitemus lacus quis preambul bela
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
* we never share your details with third parties.
Download Laser Vaporization of the Prostate
PGlmcmFtZSB3aWR0aD0iNjQwIiBoZWlnaHQ9IjM2MCIgc3JjPSJodHRwczovL3d3dy55b3V0dWJlLmNvbS9lbWJlZC9GczFoNjkxeGhhMD9yZWw9MCZzaG93aW5mbz0wIiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Download Handwashing
PGlmcmFtZSB3aWR0aD0iNjQwIiBoZWlnaHQ9IjM2MCIgc3JjPSJodHRwczovL3d3dy55b3V0dWJlLmNvbS9lbWJlZC9MMTE2T1V4S1BJVT9yZWw9MCZhbXA7c2hvd2luZm89MCIgZnJhbWVib3JkZXI9IjAiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=
* You will receive you video within 48 hours of subscribing or call us for an immediate response.
Do you want massive traffic?
Scelerisque augue ac hac, aliquet, nascetur turpis. Augue diam phasellus odio lorem integer, aliquam aliquam sociis nisi adipiscing hacac.
  • Goblinus globalus fantumo tubus dia
  • Scelerisque cursus dignissim lopatico
  • Montes vutario lacus quis preambul
  • Leftomato denitro oculus softam lorum
  • Spiratio dodenus christmas gulleria tix
  • Dualo fitemus lacus quis preambul bela
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
* we never share your details with third parties.
Rati-Fi ® Informed Consent & Patient Engaement
FREE DEMO
Dolor aliquet augue augue sit magnis, magna aenean aenean et! Et tempor, facilisis cursus turpis tempor odio putonius mudako empero brutto populius giten facilisis cursus turpis balocus tredium todo.
Thank You. We will contact you as soon as possible.
About Rati-Fi®
Let us guide you through a free demo of the Rati-Fi® Informed Consent platform.
Your Information will never be shared with any third party.
JOIN US NOW
Purus sed vel ultricies, lorem rhoncus. Augue hac, adipiscing risus, sed ac? Pid nunc dignissim, non, ac parturient sociis enim.
Your Information will never be shared with any third party.